- Scientific and clinical expertise
- Powerful know-how and tools for orthotopic and subcutaneous xenografts
- A very large bank of samples, in terms of quantity and diversity of urologic tumors and cancer cell lines
- Informed consent and clinical history of each patient
- Proof of concept in patient-derived xenograft (PDX) models
- Molecular characterization and translational research using pharmaco-imaging, analysis of target expression and signaling pathways (Western-Blot, ELISA), investigation of specific genes (RT-PCR) …
- Histological analysis
- Biomarkers identification for personalized medicine
- Pharmacological characterization with relevant standards of care
| < Prev |
|---|